M&A Deal Summary |
|
---|---|
Date | 2024-08-22 |
Target | Echelon Biosciences |
Sector | Life Science |
Buyer(s) | VION Biosciences |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
VION Biosciences is a life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications in the biochemical and life science sectors, from research to commercialization. VION Biosciences was founded in 2011 and is based in United States.
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 3 |
State (Utah) | 1 of 1 |
Country (United States) | 3 of 3 |
Year (2024) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-07-29 |
Ansh Labs
Webster, Texas, United States Ansh Labs is a company that specializes in developing and manufacturing immunoassay reagent test kits for biomedical research and clinical diagnostics. Ansh Labs provide solutions for life science researchers, physician researchers, hospitals, commercial laboratories, and public health agencies. Ansh Labs is based in Webster, Texas. |
Buy | - |